LicianPro

TNBI

Tanke Biosciences Corporation

$0.02

0.00%flat

At close · Nov 20, 2026

  • Mkt cap

    $509.29K

  • EV/Sales

    −0.20

  • P/E ratio

    —

  • FY2012 Revenue

    $28.56M

  • EPS (FY2012)

    —

  • Gross Margin (FY2012)

    34.82%

  • Profit Margin (FY2012)

    −0.74%

  • Beta

    —

  • Div yield

    —

  • Sector

    Financials

TNBI at a glance

TNBI AI brief

AI

Overview

What matters now, from SEC filings and analyst ratings

Takeaway

A takeaway appears here once the latest filing has been analyzed.

Analysts

Quant grade metrics

Sector-relative grades for valuation, growth, profitability, momentum and revisions

How it works

Financials

Earnings

Ownership

Insiders

Form 4 trades, last 90 days

All trades

No open-market insider buy or sell of TNBI since Aug 24, 2026.

Filings

Latest SEC filings

All filings

No recent SEC filings on file.

News

Latest stored headlines

TNBI — Tanke Biosciences Corporation · rev $28.6M

TNBI Key Statistics

  • Market Cap: $509.3K
  • P/B Ratio: 0.02
  • Previous Close: $0.02
  • Day Range: $0.02 – $0.02

Tanke Biosciences Corporation latest statements (FY2012)

Latest cached year on this hub. Full TNBI income, balance, and cash tables.

  • Revenue$28.6M
  • Net Income-$210.2K
  • Total Assets$28.8M

TNBI FAQ

What industry is TNBI in?

Tanke Biosciences Corporation (TNBI) is a asset management company in the Financial Services sector.

What are TNBI's latest revenue and net income?

Latest cached Tanke Biosciences Corporation (TNBI) revenue for Dec 31, 2012 was $28.6M. Net income was -$210.2K. Statements: https://lician.com/financials/tnbi

What is TNBI's market cap?

Tanke Biosciences Corporation (TNBI) market capitalization is $509.3K on the latest cached snapshot.

What are TNBI's previous close and day range?

Tanke Biosciences Corporation (TNBI) cached previous close $0.02; day range $0.02 – $0.02.

TNBI chart and investment calculator load when you scroll here.